Novavax CEO to Present at FBR Capital Markets 12th Annual Spring Investor Conference

Thursday, May 29, 2008 General News J E 4
ROCKVILLE, Md., May 28 Novavax, Inc.(Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr.Rahul Singhvi, President and Chief Executive Officer, will be presenting atthe FBR Capital Markets 12th Annual Spring Investor Conference at 9:45 am. onMay 29, 2008 at The Grand Hyatt Hotel in New York. Dr. Singhvi will provide anoverview of the company's strategy, research and development progress. A linkto the live presentation can be accessed via the Company website An archive of the presentation will be available one hourafter the event on the Novavax website for 90 days.


Novavax, Inc. is a clinical stage biotechnology company, creating novelvaccines to address a broad range of infectious diseases worldwide usingadvanced proprietary viruslike particle (VLP) technology. The Company producesthese VLP based, potent, recombinant vaccines utilizing a new, efficientmanufacturing solution. Additional information about Novavax is available and in the Company's various filings with the Securities andExchange Commission.

SOURCE Novavax, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
The MOTHERS Act: Thalidomide Revisited?
New Research and Treatment Options for Millions Su...